Hepatitis C Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model

Region:Global

Author(s):

Product Code:GDME364MM

Download Sample Report download
Buy the Full ReportStarting from $7500
Published on

May 2019

Total pages

NA

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $7500

About the Report

About the Report

Hepatitis C Tests (In Vitro Diagnostics)-Global Market Analysis and Forecast Model

Summary

Hepatitis C Tests (In Vitro Diagnostics)-Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area.

Hepatitis C is a viral infection caused by Hepatitis C virus (HCV). Hepatitis C virus is a blood borne virus that causes liver disease and can cause acute and chronic hepatitis. Infection may be caused through injection drug use, transfusion of unscreened blood products, unsafe injection practices, sexual contact and from infected mother to her baby. Diagnosis of HCV infection can be done by screening for anti-HCV antibodies along with a serological test to confirm the viral infection. Nucleic Acid Test for HCV Ribonucleic Acid (RNA) is often performed in cases to confirm chronic infection.

The World Health Organization estimates that 71 million people are living with chronic hepatitis C infection globally. Disease incidence and prevalence are not the only factors influencing the Hepatitis C Tests market. Sales of these devices are also heavily impacted by fluctuations in the number of pregnant women, semen donations, whole blood donations, and source plasma donations.

The predominant devices used for Hepatitis C detection are enzyme immunoassay (EIA) tests, owing to their high specificity and sensitivity as well as their ability to be adapted for high-throughput testing. EIA Hepatitis C devices are used for disease diagnosis as well as screening of whole blood, source plasma, and sperm donations as well as for pregnant women screening. Nucleic Acid Amplification (NAAT) tests are sometimes used as confirmatory tests for samples that have already tested positive for HCV through EIA. NAAT are also used for serial monitoring of Hepatitis C patients, to aid in management of the disease and to inform treatment strategies i.e. with anti-retroviral agents.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market Model

Currently marketed Hepatitis C Tests and evolving competitive landscape-

- Insightful review of the key industry trends.

- Annualized total Hepatitis C Tests market revenue by segment and market outlooks from 2015-2028.

- Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights-

- Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.

- SWOT analysis for the market.

- Competitive dynamics insights and trends provided for the overall market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

- Country specific overview of the healthcare system.

- Country specific reimbursement policies.

- Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Abbott Laboratories, Bio-Rad Laboratories Inc, Hologic Inc, Ortho-Clinical Diagnostics Inc, Bio Manguinhos and Fiocruz, Grifols, S.A, F. Hoffmann-La Roche Ltd (Roche Diagnostics International Ltd), Siemens Healthineers AG, Qiagen NV, bioMerieux SA, DiaSorin S.p.A., United States Biological, SeraCare Life Sciences, Inc., ThermoFisher Scientific and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for-

- CMO executives who must have deep understanding of the Hepatitis C Tests marketplace to make strategic planning and investment decisions.

- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.

- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to buy

The model will enable you to-

- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.

- Develop business strategies by understanding the trends shaping and driving Hepatitis C Tests market.

- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Hepatitis C Tests market in the future.

- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.

- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

- Track device sales in the global and country-specific Hepatitis C Tests market from 2015-2028.

- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Products

Products

Hepatitis C, pregnant women, semen donations, whole blood donations, source plasma donations, enzyme immunoassay (EIA) tests, Enzyme-linked Immunosorbent Assay (ELISA) tests, nucleic acid amplification (NAAT), viral load tests


Companies

Abbott Laboratories

Bio-Rad Laboratories Inc

Hologic Inc

Ortho-Clinical Diagnostics Inc

Bio Manguinhos and Fiocruz

Grifols S.A

F. Hoffmann-La Roche Ltd (Roche Diagnostics International Ltd)

Siemens Healthineers AG

Qiagen NV

bioMerieux SA

DiaSorin S.p.A.

United States Biological

SeraCare Life Sciences Inc.

ThermoFisher Scientific

Table of Contents

Table of Contents

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022